Dynamic Technology Lab Private LTD Spring Works Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$36.5 - $52.5 $301,490 - $433,650	8,260 New	8,260 $407,000
Q1 2023 May 12, 2023	BUY	$24.97 - $34.05 $540,600 - $737,182	21,650 New	21,650 $557,000
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $93,268 - $305,155	-5,080 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $284,515 - $380,322	-5,810 Reduced 53.35%	5,080 $287,000
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $173,758 - $247,238	3,260 Added 42.73%	10,890 $675,000
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $196,125 - $276,253	3,130 Added 69.56%	7,630 $484,000
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $303,525 - $385,335	4,500 New	4,500 $371,000

220

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $1.87B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.